Aldurazyme – Laronidase Injection
Description
LARONIDASE (ALDURAZYME) INJECTION – TREATMENT FOR MUCOPOLYSACCHARIDOSIS
Aldurazyme contains a compound that occurs naturally in healthy people’s bodies. A few people are deficient in this catalyst due to a genetic defect. In such cases, Laronidase replaces the missing chemical.
Laronidase is used to treat some of the symptoms of a hereditary condition known as mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sister), also known as Hurler disorder, Hurler-Scheie disorder, or Scheie disorder.
MPS I is a metabolic disorder in which the body lacks the compound required to separate certain substances. These substances can accumulate in the body, resulting in enlarged organs, unusual bone structure, changes in facial highlights, breathing issues, heart issues, vision or hearing issues, and changes in mental or physical capacities.
An unfavorably susceptible response may occur during or shortly after the implantation of this drug (up to 3 hours later). In the event that you have any indications of an extreme hypersensitive response, for example, notify your parental figures or seek crisis therapeutic help right away.
• rapid breathing or apprehension about taking a breath;
• wheezing, chest tightness
• feeling as if you could go out even while resting;
• rapid or moderate pulses
• perspiring, cold or damp skin;
• fair skin; or
• blue lips or fingernails.
